Oncolytics Biotech (ONC) Set to Announce Earnings on Thursday

Oncolytics Biotech (TSE:ONC) will post its quarterly earnings results after the market closes on Thursday, August 1st. Analysts expect Oncolytics Biotech to post earnings of C($0.10) per share for the quarter.

Oncolytics Biotech (TSE:ONC) last posted its quarterly earnings data on Thursday, May 9th. The company reported C($0.09) EPS for the quarter, topping analysts’ consensus estimates of C($0.12) by C$0.03.

Oncolytics Biotech Stock Down 2.7 %

ONC stock opened at C$1.43 on Wednesday. Oncolytics Biotech has a 12-month low of C$1.20 and a 12-month high of C$3.48. The company has a quick ratio of 8.86, a current ratio of 8.14 and a debt-to-equity ratio of 4.91. The company has a market cap of C$107.85 million, a price-to-earnings ratio of -3.58 and a beta of 1.49. The company has a 50 day moving average of C$1.42 and a two-hundred day moving average of C$1.47.

Analysts Set New Price Targets

Separately, Raymond James set a C$3.00 target price on shares of Oncolytics Biotech and gave the stock an “outperform” rating in a research report on Thursday, April 4th.

Oncolytics Biotech Company Profile

Oncolytics Biotech Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma.